GTx

At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.

GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.

Number of Funding Rounds

Total Funding Amount

1

$20M

GTx has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Aug 20, 2003 from a Series E round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 20, 2003	Series E	$20M	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

1

GTx is funded by 1 investors. Oracle are the most recent investors.

Investor Name	Lead Investor	Funding Round
Oracle	—	Series E